Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Myelination of axons by oligodendrocytes enables rapid impulse propagation in the central nervous system. But long-term interactions between axons and their myelin sheaths are poorly understood. Here we show that Cnp1, which encodes 2',3'-cyclic nucleotide phosphodiesterase in oligodendrocytes, is essential for axonal survival but not for myelin assembly. In the absence of glial cyclic nucleotide phosphodiesterase, mice developed axonal swellings and neurodegeneration throughout the brain, leading to hydrocephalus and premature death. But, in contrast to previously studied myelin mutants, the ultrastructure, periodicity and physical stability of myelin were not altered in these mice. Genetically, the chief function of glia in supporting axonal integrity can thus be completely uncoupled from its function in maintaining compact myelin. Oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A direct role for oligodendrocytes to sustain axonal function is supported by the observation that mice lacking 2′,3′-cyclic nucleotide phosphodiesterase (CNPase) or proteolipid protein (PLP) display axonal dysfunction without demyelination in the spinal cord and brain [86,87].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [87]
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Silver Staining of Myelin by Means of Physical Development
Gallyas, F. (1979) · Neurological Research · doi:10.1080/01616412.1979.11739553 · Cited by 935
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationRd, H. (1948) · PubMed · Cited by 872
CNS Myelin and Sertoli Cell Tight Junction Strands Are Absent in Osp/Claudin-11 Null Mice
Gow, A., Southwood, C. M., Li, J. S., Pariali, M., Riordan, G. P., Brodie, S. E., Danias, J., Bronstein, J. M., Kachar, B., & Lazzarini, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81553-6 · Cited by 699
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Gene targeting: a practical approach.
Joyner, A. L. (1993) · Cited by 575
Giese, K. P., Martini, R., Lemke, G., Soriano, P., & Schachner, M. (1992) · Cell · doi:10.1016/0092-8674(92)90591-y · Cited by 502
Assembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471
Self-citation
Cited by
Items 801–900 of 1,000
Oligodendroglial physiology and function
Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00017-1 · Cited by 4
Izagirre‐Urizar, L., Mora-Huerta, L., Soler-Sáez, I., Morales‐Gallel, R., Masson, M. L. P., Ulloa-Navas, M. J., Chara, J. C., Calovi, S., Deboux, C., Merino‐Cacho, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74488-w · Cited by 4
“This support depends not only on the presence of myelin but also on its composition 64 – 66 , presumably because molecular alterations in myelin can affect metabolite and organelle provision to the axons by oligodendrocytes via myelinic channels 67 – 69 .”
Animal models for cell and gene therapy in myelin disease
Schmandt, T., Goßrau, G., Kischlat, T., Opitz, T., & Brüstle, O. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.11.007 · Cited by 5
Heflin, J. K., & Sun, W. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.769809 · Cited by 4
“…in vivo using AAVs with oligodendrocyte-specific promoters, such as myelin basic protein or myelin-associated glycoprotein (Chen et al., 1998; Lawlor et al., 2009; Von Jonquieres et al., 2016), or packaging AAV vectors with a novel oligotropic capsid (Powell et al., 2016; Weinberg et al.,…”
MethodKeller, S. H., Johnson, G. S., Bullock, G., Mhlanga-Mutangadura, T., Schwartz, M., Pattridge, S. G., Guo, J., Kortz, G. D., & Katz, M. L. (2024) · Genes · doi:10.3390/genes15020246 · Cited by 4
2′,3′-cyclic nucleotide phosphodiesterase (CNPase) as a target in neurodegenerative diseases
Baburina, Y. L., Krestinina, O. V., & Azarashvili, T. (2013) · Neurochemical Journal · doi:10.1134/s1819712412040034 · Cited by 5
Stokely, M. E., Garg, P., Bhat, M. A., & Koulen, P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21645 · Cited by 4
“These end points were selected for assay for the following reasons: The marker proteins mCNPase and PN were selected for their critical roles in normal oligodendrocyte-axon interactions, assessed from the standpoint of oligodendrocyte contributions to axonal survival (mCNPase) and from the standpoint of axonal contrib…”
BackgroundMethodInfluentialThe Neuropathology of Progressive Multiple Sclerosis
Bø, L., Evangelou, N., & Tallantyre, E. C. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_4 · Cited by 4
“Oligodendrocytes have been recognized as ful fi lling roles of axonal support above and beyond their contribution to CNS myelination [ 75 ] .”
BackgroundAlexander, C. J., Wagner, W., Copeland, N. G., Jenkins, N. A., & Hammer, J. A. (2018) · Cytoskeleton · doi:10.1002/cm.21474 · Cited by 4
Waldhauser, V., Baroti, T., Fröb, F., & Wegner, M. (2023) · Cells · doi:10.3390/cells12121556 · Cited by 3
Levy, G., Rokach, M., Fischer, I., Kimchi-Feldhorn, O., Shoob, S., Bar, E., Rosenberg, T., Bartman, J., Parnas, H., Grad, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63500-4 · Cited by 3
“The myelin sheath is an insulating multi-lamellar membrane surrounding axons that is produced by OLs 1 in the CNS and by SCs in the PNS 2 .”
InfluentialWu, H., Chen, D., Li, J., Zhou, T., Zhuang, Z., Niu, Z., Du, Z., Chen, Y., Chuan, S., Xu, C., et al. (2026) · Science · doi:10.1126/science.aea2535 · Cited by 4
Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression
Correale, J. D., Ysrraelit, M. C., & Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000005339 · Cited by 3
Fimiani, C., Pereira, J. A., Gerber, J., Berg, I., DeGeer, J., Bachofner, S., Fischer, J. S., Kauffmann, M., & Suter, U. (2024) · Glia · doi:10.1002/glia.24642 · Cited by 3
Cell-specific Eif2b5 mutant mice: novel insights into roles of macroglia in vanishing white matter
Triñanes-Ramos, J., Bugiani, M., Leeuwen, G. V. R.-V., Chevalier, J. A., Siu, Y. J., van Utenhove, E. L. H., Hoogterp, L., Witkamp, D., Oudejans, E., Lodder, B., et al. (2025) · Brain · doi:10.1093/brain/awaf171 · Cited by 5
Self-citationAbe, Y., Tamura, S., Honsho, M., & Fujiki, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_10 · Cited by 3
Hay, C. M., Jackson, S., Mitew, S., Scott, D. J., Koenning, M., Bensen, A. L., Bujalka, H., Kilpatrick, T. J., & Emery, B. (2021) · Neural Development · doi:10.1186/s13064-021-00156-y · Cited by 6
Dion, V., Schumacher, N., Masar, N., Pieltain, A., Tocquin, P., Lesoinne, P., Malgrange, B., Vandenbosch, R., & Franzen, R. (2022) · Glia · doi:10.1002/glia.24186 · Cited by 4
“To specifically knock-out Cdk7 in post-mitotic oligodendrocytes, mice with Cdk7 floxed genes (Ganuza et al., 2012) were crossed with mice expressing the Cre-recombinase gene under the control of the Cnp1 regulatory sequence (Lappe-Siefke et al., 2003).”
BackgroundMethodInfluentialCampos-Ordoñez, T., González-Granero, S., Eudave-Patiño, M., Buriticá, J., Herranz‐Pérez, V., García‐Verdugo, J. M., & González-Pérez, Ó. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114412 · Cited by 3
Wu, L., Wang, F., Moncman, C. L., Pandey, M., Clarke, H. A., Frazier, H. N., Young, L. E. A., Gentry, M. S., Cai, W., Thibault, O., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20384 · Cited by 3
“7) but do not develop the spontaneous epilepsy or aberrant coordinated movements observed in many mouse models of myelinopathy [48,84].”
BackgroundCharacterization of hyperpolarization-activated cyclic nucleotide-gated channels in oligodendrocytes
Lyman, K. A., Han, Y. S., Robinson, A. P., Weinberg, S. E., Fisher, D. W., Heuermann, R. J., Lyman, R. E., Kim, D., Ludwig, A., Chandel, N. S., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1321682 · Cited by 4
Characterization and role of a 2′,3′-cyclic phosphodiesterase from Deinococcus radiodurans
Han, W., Zhou, C., Cheng, J., Pan, M., Hua, Y., & Zhao, Y. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2349-7 · Cited by 3
Structure and Function of Oligodendrocytes
Butt, A. M. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0006 · Cited by 12
Sattler, R., & Rothstein, J. D. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0063 · Cited by 3
Cho, S.-J., Jung, J. S., Shin, S. C., Jin, I., Ko, B. H., Kwon, Y. K., Suh‐Kim, H., & Moon, I. S. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.63 · Cited by 4
“Indeed, recent findings by Lappe-Siefke et al. (2003) revealed that Cnp1, a gene that encodes both CNP1 and CNP2 in oligodendrocytes, is essential for axonal survival but not for myelin assembly.”
BackgroundClinical Trials of Gene Therapy for Canavan Disease
Klugmann, M., & Leichtlein, C. B. (2006) · Elsevier eBooks · doi:10.1016/b978-012397632-1/50024-1 · Cited by 4
Sumiyoshi, K., Obayashi, S., Tabunoki, H., Arima, K., & Satoh, J. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01035.x · Cited by 3
“CNP is a valid cell type-specific marker for oligodendrocytes, essential for axonal support but not for myelin assembly.(15) CNP acts as a membrane anchor for tubulin required for process outgrowth of oligodendrocytes,(16,17) and ubiquitinated CNP is concentrated within lipid rafts,(18) suggesting that CNP expressed i…”
BackgroundNF-κB RelA regulates temporal oligodendrocyte differentiation in the postnatal brains
Sompub, K., Bizen, N., Baldwin, A. S., & Takebayashi, H. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1622874 · Cited by 2
Disrupted Myelination in FAHN: Insights from a Patient-Specific hiPSC Neuron–Oligodendrocyte Model
Efendic, F., Hermann, A., & Frech, M. J. (2025) · Cells · doi:10.3390/cells14161261 · Cited by 2
“The late-onset axonal degeneration observed in FA2H − / − aged mice has also been described in other mouse mutants deficient in myelin-specific genes, including PLP [30] and CNP [31].”
Jiang, M., Li, C., Xie, B., Li, T., Dai, Z., & Qiu, M. S. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0371-25.2025 · Cited by 3
Furusho, M., Das, B., Yan, R., Bansal, R., & Ishii, A. (2025) · Glia · doi:10.1002/glia.70123 · Cited by 2
Dyckow, J., Rabitsch, A. M., Geywitz, C., Mayer, C., Lerma-Martin, C., Ludwig, N., Smith, M. D., Potschka, H., Calabresi, P. A., Nave, K., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10530-3 · Cited by 3
“Cnp-Cre knock-in mice were transferred from the Max Planck Institute in Goettingen and had been generated as previously described 67 .”
Self-citationYoung, A. R., Galfano, A., Reyngoudt, J., Lewis, R. W., Cash, M., Polis, B., Zalusky, M., Datta, A. V., & Bechler, M. E. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003992 · Cited by 3
“…(cKO), homozygous Piezo1 fl/fl animals were crossed with mice with heterozygous expression Cre recombinase under the control of the 2 ′‐ 3 ′ cyclic nucleotide phosphodiesterase (CNP) gene [45] to generate flox control (CNP WT/WT ; Piezo1 fl/fl ) and cKO littermates (CNP WT/Cre ; Piezo1 fl/fl ).”
Evolution of Myelinated Nervous Systems
Roots, B. I., & Gould, R. M. (2007) · Elsevier eBooks · doi:10.1016/b0-12-370878-8/00187-7 · Cited by 2
Guo, H., Liu, Y., Gu, J., Luo, J., Ma, Y., & Xiao, F. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.10.029 · Cited by 2
Myelinodegeneration vs. Neurodegeneration in MS Progressive Forms
Nataf, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021596 · Cited by 2
Matsuoka, M., Sakai, D., Shima, H., & Watanabe, T. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149353 · Cited by 2
Johansen, M., Haskell, G., Arreola, A., Riordan, C., Gadi, I. K., Penton, A. L., Papenhausen, P. R., & Schwartz, S. (2024) · Prenatal Diagnosis · doi:10.1002/pd.6554 · Cited by 2
Remyelination in Multiple Sclerosis – How Close are We?
Palavraa, L. A. F. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000192 · Cited by 4
Muruganandam, G., Raasakka, A., Myllykoski, M., Kursula, I., & Kursula, P. (2017) · BMC Biochemistry · doi:10.1186/s12858-017-0084-2 · Cited by 2
“CNPasedeficient mice develop progressive motor deficits and die prematurely due to diffuse brain axonal swelling and neurodegeneration [20].”
BackgroundBeller, A. H. (1977) · Cited by 2
The Neuropathology of Progressive Multiple Sclerosis
Evangelou, N., Paine, S., & Tallantyre, E. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_3 · Cited by 3
Excitotoxicity and Axon Degeneration
King, A. E., & Vickers, J. C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_145 · Cited by 2
“Mouse models with knockout of the oligodendrocyte proteins plp and CNP have frequent axonopathy characterized by axonal swelling and cytoskeletal disruption (Lappe-Siefke et al. 2003; Edgar et al. 2004).”
BackgroundFuture Therapies for Progressive Multiple Sclerosis
Scolding, N. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_10 · Cited by 2
“Axon loss secondary to demyelination, long known to occur in the peripheral nervous system, has been shown to occur in the CNS through by a variety of mechanisms, including sustained (demyelination-induced) conduction block and electrical silence [ 14 ] , increased vulnerability of the exposed axon to injurious agents…”
BackgroundAlcohol and Its Impact on Myelin
Guerri, C., & Pascual, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00039-0 · Cited by 2
Clayton, B. L. L., Allan, K. C., Nevin, Z. S., Elitt, M. S., & Tesar, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00013-6 · Cited by 2
Oruz, O., Yar, K., Şaker, D., Açıkalın, A., Dağlıoğlu, Y. K., & Polat, S. (2022) · Ultrastructural Pathology · doi:10.1080/01913123.2021.2022055 · Cited by 2
“Oligodendrocytes are essential cells to protect the neuron cell body, axonal survival, and myelin sheath structure.(18,19) The rapid and progressive loss of oligodendrocyte functions can explain demyelination in many optic neuropathies, including NAAION observed in both our study and in humans.”
BackgroundSakamoto, Y., Tanaka, N., Ichimiya, T., Kurihara, T., & Nakamura, K. T. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904024126 · Cited by 2
Abhilash, P. L., Bharti, U., Anand, L., Sagar, B. K. C., & Alladi, P. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3659630/v1 · Cited by 2
Ghezzi, L., Kuenen, S., Pech, U., Schoovaerts, N., Kilic, A., Poovathingal, S., Davie, K., Lamote, J., Praschberger, R., & Verstreken, P. (2025) · eLife · doi:10.7554/elife.105386 · Cited by 2
“In oligodendrocytes, maintaining myelin sheaths is critical ( Ettle et al., 2016 ; Lappe-Siefke et al., 2003 ).”
Keatinge, M., Juhasz, S. C., Shaw-McGrath, T., Albayrak, J., Soong, D. Y. H., Marshall-Phelps, K. L., Story, D., Hoodless, L. J., Cooper, J. D., Almeida, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.17.688801 · Cited by 2
Ройтберг, Г. Е., Smirnov, I. V., Kondratova, N. V., Бакланов, А. Н., Strunin, O. V., Katayev, A. A., & Владимирович, Г. Е. (2024) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj2024124601-616 · Cited by 1
Hümmert, S., de Faria, J. P., Jahn, O., Bilgin, E., Łukasik, N., Rao, C., Mitkovski, M., Benseler, F., Brose, N., Siems, S. B., et al. (2026) · Glia · doi:10.1002/glia.70134 · Cited by 1
Self-citationWellman, S. M., Guzman, K., Suematsu, N., Thai, T. T. D., Tung, T.-H., Padilla, C. G., Sridhar, S., Chen, K., Cambi, F., & Kozai, T. D. Y. (2026) · Journal of Neural Engineering · doi:10.1088/1741-2552/ae4d8b · Cited by 2
Metabolic Symbiosis and Vulnerability in the CNS Axon-Myelin Unit
Miao, K., Meng, M., Liu, L., Li, M., Bai, Y., Guo, Y., Zhang, G., Kong, J., & Mu, J. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01729-3 · Cited by 2
“…the roles of proteins involved in myelin development and production (Brady et al. 1999; Edgar et al. 2009; Fruttiger et al. 1995 ; Griffiths et al. 1998; Kirkpatrick et al. 2001; Klugmann et al. 1997; Lappe-Siefke et al. 2003; Nguyen conduction and ectopic action potentials (Hamada and Kole 2015).”
Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease
Arlt, F. A., Miske, R., Appeltshauser, L., Zinnow, V., Borowski, K., Stenzel, W., Radbruch, H., Meisel, A., Ruprecht, K., Endres, M., et al. (2026) · Brain : a journal of neurology · doi:10.1093/brain/awag183
Tung, T.-H., Babu, S., Tang, X., Sciutto, A. L., Romer, M. A., Racha, P., 徐, R. 榕. X., Fiesler, V. M., Saha, A., Thai, T., et al. (2026) · Brain · doi:10.1093/brain/awag234 · Cited by 1
Exosomes: Mechanisms, Diagnosis, and Therapeutic Progress in Vascular Cognitive Impairment
Wu, Z., & Kong, N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06161-8 · Cited by 1
“Studies have indicated that the deficiency of 2 ′ ,3 ′ -cyclic nucleotide 3 ′ -phosphodiesterase (CNP) is closely related to the occurrence and development of various neurological diseases [83, 84].”
Hassan, Z. A., El-Haleem, M. R. A., & Amer, M. G. (2012) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000413360.30968.09 · Cited by 1
Nanobodies against the myelin enzyme CNPase as tools for structural and functional studies
Markusson, S., Raasakka, A., Schröder, M., Sograte‐Idrissi, S., Rahimi, A. M., Asadpour, O., Körner, H., Lodygin, D., Eichel‐Vogel, M. A., Chowdhury, R., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16274 · Cited by 1
Neuroprotection in Demyelinating Diseases: The Therapeutic Potential of the Neurotrophins
Xiao, J., Hughes, R. A., & Murray, S. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_36 · Cited by 1
Neural Stem Cells and Demyelinating Disease
Crawford, A. H., & Franklin, R. J. M. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-1908-6_8 · Cited by 1
“Brainstorming”: Extracellular Vesicles in Physical Activity and Neuronal Health
Brahmer, A., & Krämer‐Albers, E. (2020) · Trillium Extracellular Vesicles · doi:10.47184/tev.2020.01.07 · Cited by 1
Dcf1 deficiency induces hypomyelination by activating Wnt signaling
Feng, R., Wang, J., Luo, G., Wang, H., Shi, J., & Wen, T. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113486 · Cited by 3
Myelination, oligodendrocyte development, and associated neurodevelopmental disorders
Mohamed, E. M., Bigbee, J., & Sato-Bigbee, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817986-4.00016-x · Cited by 1
Garbern, J. Y. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch20 · Cited by 1
Kim, Y., Park, K., Lee, E., & Yoon, Y. W. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15976 · Cited by 1
“CNPase-deficient mice show a loss of motor function due to axonal loss (Lappe-Siefke et al., 2003).”
BackgroundKorn, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00004-x · Cited by 1
Comisi, F. F., Fusco, C., Mura, R., Cerruto, C., D’Agruma, L., Carnazzo, S. M., Castori, M., & Savasta, S. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.64052 · Cited by 1
Delaunay-Piednoir, B., Pouettre, E., Etard, O., Goux, D., Baudron, E., Docagne, F., Maubert, E., Vivien, D., & Bardou, I. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02110-z · Cited by 1
“CNP-Cre mice were obtained from Dr. Klaus-Armin Nave (Max Planck Institute for Experimental Medicine) [23].”
Mouse Models of Receptor Tyrosine Kinases
Holcmann, M., Amberg, N., Drobits, B., Glitzner, E., Komposch, K., Robson, J., Savarese, F., Srivatsa, S., Stulnig, G., & Sibilia, M. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2_11 · Cited by 1
Procesy patologiczne w mózgu podczas jego niedokrwienia
Kacperska, M. J., Jastrzębski, K., & Glabinski, A. R. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Axonal Loss and Neurodegeneration in Multiple Sclerosis
Dutta, R., Chen, J. M., Ohno, N., Ontaneda, D., & Trapp, B. D. (2017) · Wiley eBooks · doi:10.1002/9781118661895.ch20 · Cited by 1
Magnetic resonance imaging of animal brain in vivo
Frahm, J., Natt, O., Watanabe, T., Boretius, S., & Michaelis, T. (2006) · Max Planck Institute for Plasma Physics · Cited by 1
Schädigungs- und Reparaturmechanismen in Multiple-Sklerose-Läsionen
Kuhlmann, T. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1628689 · Cited by 1
Damage and Repair in Experimental Cortical Demyelination
Garea‐Rodríguez, E. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3318 · Cited by 1
Characterization of axon-Schwann cell interactions implicated in neuronal energy metabolism
Filipe, A. C. T. M. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9bt2-fk22 · Cited by 1
Cell type specific transcriptomic characterization of myelin abnormalities
Sun, T. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9413 · Cited by 1
Lei, J., Zhong, S., Fan, R., Shu, X., Wang, G., Guo, J., Xue, S., Zheng, L., Ren, A., Ji, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.27.577548 · Cited by 1
Ding, T., Schweickart, G., Kaiser, K., Rivaldi, A., Marchal, N., Harrington, C. A., Varghese, A., Qin, K., Kelly, B., Sunkel, B. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.21.677597 · Cited by 1
Activation of cannabinoid receptor CB1 leads to aberrant myelination in developmentPreprint
Miramontes, T. G., Hamling, K. R., Doan, R. A., Singh, S., Collins, H. Y., Emery, B., Call, C. L., & Monk, K. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693544 · Cited by 1
Gargareta, V., Mougios, N., Hahn, E. T., Siems, S. B., Crisp, S. J., Varga, B. V., Káradóttir, R. T., Buescher, J. M., Jung, R. B., Ramesh, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.730898 · Cited by 1
Self-citationCohen, J. A., & Rudick, R. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.004
Schwann Cell–Axon Interactions: The Molecular and Metabolic Link Between Schwann Cells and Axons
Ohno, N., Sakoh, T., Saitoh, Y., Terada, N., & Ohno, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54764-8_4
Is Multiple Sclerosis a Neurodegenerative Disorder?
Dutta, R., & Trapp, B. D. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00019-x · Cited by 2
The Role of Schwann Cell Mitochondrial Metabolism in Schwann Cell Biology and Axonal Survival
Viader, A. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7319sxj
“…in the central nervous system (CNS), where oligodendrocytes (OLs) also preserve axonal integrity 6 independent of myelin (Griffiths et al., 1998; Lappe-Siefke et al., 2003), mutations in some myelin proteins cause axonal loss (Griffiths et al., 1998) while others cause severe dysmyelination…”
BackgroundThe contribution of brain reorganisation to recovery inpatients with optic neuritis
Jenkins, T. M. (2010) · UCL Discovery (University College London)
Neurofilament Changes in Multiple Sclerosis
Gray, E., & Wilkins, A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_16
Oligodendrocyte and Schwann Cell Identification Methods
Trotter, J., & Karram, K. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01750-2
Mechanisms and Patterns of Axonal Loss in Multiple Sclerosis
Mayo, Z., & Jacob, A. (2012) · InTech eBooks · doi:10.5772/35703
Mechanisms of Axonopathy in Krabbe Disease
Cantuti‐Castelvetri, L. (2012) · Figshare
Dowling, P. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1362
Glial cell reactivity in mouse models reflecting different aspects of Alzheimer's disease
Behrendt, M. G. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14767
López, J. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1090
Axon Maintenance and Degeneration
Wang, F., & He, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397266-8.00126-5 · Cited by 1
The cellular prion protein in multiple sclerosis: A potential target for neurotherapeutics?
Antony, J. M. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0042-1
Ozawa, T. (2012) · Movement Disorders · doi:10.1002/mds.25177
Funktionelle Rolle von SNARE-Proteinen bei der Myelinisierung
Feldmann, A. (2009) · Gutenberg Open Science · doi:10.25358/openscience-4319
“Ein Oligodendrozyt kann bis zu 40 verschiedene Axone myelinisieren (Baumann and Pham-Dinh, 2001; Salzer, 2003).”
InfluentialGarbern, J. Y. (2008) · Springer eBooks · doi:10.1007/0-387-25518-4_4
Watson, A. L. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Metadata
- Authors
- Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- Max Planck Society (DE)
- McGill University (CA)
- University of Glasgow (GB)
- Corresponding author
- Nave, Klaus-Armin
- Venue
- Nature Genetics
- Published
- 2003-02-18
- Volume
- 33
- Issue
- 3
- Pages
- 366-374
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2000485285
- Cited by
- 1,036
- References
- 52
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 46 · 2023: 51 · 2022: 38 · 2021: 40 · 2020: 48 · 2019: 52 · 2018: 48 · 2017: 53 · 2016: 44 · 2015: 57 · 2014: 56 · 2013: 49 · 2012: 51
- FWCI
- 24.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Cnp1, cyclic nucleotide phosphodiesterase, oligodendrocytes, myelination, axonal swellings, neurodegeneration, hydrocephalus, myelin ultrastructure, axonal integrity, multiple sclerosis
- MeSH terms
- Animals, Axons, Cytoskeleton, Female, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Myelin Sheath, Nerve Degeneration, Oligodendroglia, Phenotype, 2',3'-Cyclic-Nucleotide Phosphodiesterases, Mice, Knockout, Gene Targeting, Heredodegenerative Disorders, Nervous System, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.